Hims & Hers stock rebounded 4.4% after hours following a 34% plunge, its worst drop ever, after Novo Nordisk cut ties over Wegovy concerns. CEO Andrew Dudum hit back at Novo's claims, defending Hims' practices. Despite the split, retail sentiment turned extremely bullish, with volume up by 6,717%.